Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Concussion Issues Author: Last Updated: Sep 7, 2017 - 10:06:33 PM



Researchers Find Potential Therapy for Brain Swelling During Concussion

By
Nov 23, 2016 - 9:29:22 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - FAYETTEVILLE, Ark. – A team of biomedical engineering researchers at the University of Arkansas have identified a cause of fluid swelling of the brain, or cellular edema, that occurs during a concussion.

The researchers discovered that pre-treating the cells with an existing, FDA-approved drug used for epilepsy and altitude sickness reduces the expression of a specific protein that causes swelling.

Their findings were published in a recent issue of Nature’s Scientific Reports.

“Our study found that mild traumatic brain injury resulted in increased expression of a protein called aquaporin-4, which caused a massive cellular influx of fluid, leading to increased astrocyte cell volume and injury,” said Kartik Balachandran, assistant professor of biomedical engineering. “We then worked with a drug called Acetazolamide. Our results showed that Acetazolamide minimized cell swelling and injury, suggesting a therapeutic role for this drug in reducing the detrimental effects of concussions.”

In addition to Balachandran, who led the study, the research was conducted by Nasya Sturdivant, biomedical-engineering doctoral candidate; Jeffrey Wolchok, assistant professor of biomedical engineering; and partners at the FDA’s National Center for Toxicological Research in Jefferson, Arkansas.

Mild traumatic brain injury, also known as a concussion, is a devastating condition that is commonly experienced in car accidents, full-contact sports and battlefield injuries. One of the main factors that leads to the high death rate in patients who experience mild traumatic brain injury is the swelling or edema of astrocytes, the most abundant cell type in the brain.

The researchers engineered a benchtop bioreactor to examine astrocyte cells. This device helped them see that mild traumatic brain injury led to an increased expression of aquaporin-4, the protein that causes a large cellular influx of fluid, which in turn leads to increased astrocyte cell volume.

“This study demonstrates the collaborative neuro-engineering efforts that are contributing to both diagnostic and therapeutic methods for addressing traumatic brain injury,” said Raj Rao, professor and chair of the Department of Biomedical Engineering at the University of Arkansas.
The research was funded by the National Science Foundation.

###

For advertising/promo contact Mike McCurdy at [email protected]althNewsDigest.com or call him at 877-634-9180



Top of Page

HealthNewsDigest.com

Concussion Issues
Latest Headlines


+ Women May be More Vulnerable to Concussions Because of 'Leaner' Nerve Fibers
+ Molecules in Spit May Be Able to Diagnose and Predict Length of Concussions
+ Back on Ice, But Young Hockey Players’ Brains Still Recovering from Concussion
+ Youth Football: How Young Athletes Are Exposed to High-Magnitude Head Impacts
+ Concussion: How the NFL Came to Shape the Issue that Plagued It
+ One in Five Teens Report Having Had a Concussion in Their Lifetime
+ Exposure to Head Impacts in Youth Football Practice Drills
+ Rugby Players Take Part in Ground-Breaking Concussion Study
+ Mobile App Improves Concussion Symptoms, Optimism
+ Back-to-school Concussion Screening (VIDEO)



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions